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Anesthetic-sensitive ion channel
modulation is associated with a molar
water solubility cut-off
Robert J. Brosnan* and Trung L. Pham
Abstract
Background: NMDA receptor modulation by hydrocarbons is associated with a molar water solubility cut-off.
Low-affinity phenolic modulation of GABAA receptors is also associated with a cut-off, but at much lower molar
solubility values. We hypothesized that other anesthetic-sensitive ion channels exhibit distinct cut-off effects
associated with hydrocarbon molar water solubility, and that cut-off values are comparatively similar between
related receptors than phylogenetically distant ones.
Methods: Glycine or GABAA receptors or TREK-1, TRESK, Nav1.2, or Nav1.4 channels were expressed separately in
frog oocytes. Two electrode voltage clamp techniques were used to study current responses in the presence and
absence of hydrocarbon series from eight functional groups with progressively increasing size at saturated aqueous
concentrations. Null response (cut-off) was defined by current measurements that were statistically indistinguishable
between baseline and hydrocarbon exposure.
Results: Ion channels exhibited cut-off effects associated with hydrocarbon molar water solubility in the following
order of decreasing solubility: Nav1.2 ≈ Nav1.4 ≳ TRESK ≈ TREK-1 > GABAA >> glycine. Previously measured solubility
cut-off values for NMDA receptors were intermediate between those for Nav1.4 and TRESK.
Conclusions: Water solubility cut-off responses were present for all anesthetic-sensitive ion channels; distinct cut-off
effects may exist for all cell surface receptors that are sensitive to volatile anesthetics. Suggested is the presence of
amphipathic receptor sites normally occupied by water molecules that have dissociation constants inversely related
to the cut-off solubility value. Poorly soluble hydrocarbons unable to reach concentrations sufficient to out-compete
water for binding site access fail to modulate the receptor.
Keywords: Anesthesia, Mechanism, Ion channel, Electrophysiology, Aliphatic
Background
Protein-ligand interactions are commonly described using
a “lock-and-key” model in which the protein and ligand
have to fit together to have a chemical effect [1]. Although
inhaled anesthetics are presumed to exert their effects
through ion channels and cell surface receptor proteins,
the diverse nature of both anesthetic ligands and the pro-
teins they modulate challenge assumptions of a conserved
complementary structure [2, 3]. Current and historical
inhaled anesthetics include single atoms, triatomic mole-
cules, various alkanes (with and without halogens), various
ethers (with and without halogens), and various alkenes
(with and without halogens); experimental inhaled anes-
thetics demonstrate even greater structural variety. Hence,
these drugs act as structurally diverse keys that each can
open the same lock. Moreover, a single inhaled anesthetic
can allosterically modulate function of a large number
of structurally diverse and phylogenetically unrelated
ion channels—including many different ligand-gated ion
channels, voltage-gated ion channels, and leak channels—
and cell surface receptors—including many different
channel-linked receptors, enzyme-linked receptors, and
G protein-coupled receptors. Hence, these agents also
act like a key that can open many different locks.* Correspondence: rjbrosnan@ucdavis.edu
Department of Surgical and Radiological Sciences, School of Veterinary
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Inhaled anesthetics typically have high median effective
concentrations consistent with low-affinity target interac-
tions [4], and these agents can bind multiple amphipathic
sites on a protein of which at least some may be associated
with water molecules [5]. Anesthetic modulation of protein
function firstly depends upon the presence of an agent
in sufficient concentration to desolvate, displace weakly-
bound water molecules within an allosteric binding site,
and only then bind to the allosteric site. We postulate that
drugs with insufficient water solubility to competitively
displace water from this amphipathic allosteric site would
be unable to bind and modulate the protein—a cut-off
effect—even at a saturated aqueous phase drug concentra-
tion. These low-affinity amphipathic drug-receptor inter-
actions could be associated with different hydrocarbon
solubility cut-off values for different proteins since the
water dissociation constants within critical allosteric sites
could also be different for different proteins. In support,
N-methyl-d-aspartate (NMDA) receptor whole-cell currents
are unchanged by saturated concentrations of organic
compounds once the hydrocarbon ω-end or ring size is
increased such that the predicted molar water solubility
is less than approximately 1.1 mM; yet these same hydrocar-
bons still are able to allosterically modulate γ-aminobutyric
acid receptor type A (GABAA) currents [6]. However,
GABAA receptors may have their own hydrocarbon cut-off,
as GABAA receptor whole-cell currents are unchanged by a
series of substituted phenol and benzene rings once the
predicted molar water solubility of these compounds is
less than 0.1 mM [7].
We hypothesize that cut-off effects associated with molar
water solubility is a generalizable feature of inhaled
anesthetic-sensitive ion channels and receptors. As a
test, we evaluated responses of anesthetic-sensitive
channels and receptors to eight different functional
groups of organic compounds, differing only by carbon
additions to the ω-end of a chain or to a ring, so that
we could study compounds of different molecular volumes
and carbon atoms but similar molar water solubility values
(and vice versa) and therefore distinguish between effects
caused by drug size versus solubility. Although inhaled
anesthetics bind many different proteins, we studied six
channels and receptors reported to contribute to immobil-
izing effects in vivo: voltage-gated sodium channels type II
and type IV (Nav1.2 and Nav1.4), [8] TWIK-related spinal
cord channel (TRESK) [9], TWIK-related potassium
channel type I (TREK-1) [10], GABAA receptors [11],
and glycine receptors [12].
Methods
Oocyte collection
Adult female Xenopus laevis vivarium-maintained frogs
(Xenopus Express, Brooksville, FL) were anesthetized with
chilled 0.2% buffered tricaine, surgically ovariectomized,
and were either administered morphine analgesia and re-
covered from anesthesia (first ovariectomy) or euthanized
(second ovariectomy) by decapitation and double pithing
while anesthetized. The theca externa and mesovarium of
the removed ovary were disrupted manually, and oocytes
were defolliculated enzymatically by use of 0.2% collage-
nase. Oocytes were stored in a modified Barth’s electrolyte
solution until ready for use. This protocol was approved
by the Institutional Animal Care and Use Committee at
the University of California, Davis.
Receptor expression
Each anesthetic-sensitive receptor type was separately
expressed in different oocytes by injecting plasmids
containing sequences for receptor subunits which were
provided as gifts from the laboratory of R. Adron Harris
(University of Texas, Austin). All plasmids were sequenced
and their identity confirmed by comparison to National
Center for Biotechnology Information databases. Human
voltage-gated Type II sodium channels (Nav1.2) were
expressed by intracytoplasmic injection of 5 ng RNA per
oocyte containing the SCN2A gene; human voltage gated
Type IV sodium channels (Nav1.4) were similarly expressed
using RNA encoding the SCN4A gene. The human TRESK
channel (K2P18.1) was expressed by intracytoplasmic
injection of 5 ng RNA per oocyte containing the KCNK18
gene; the human TREK-1 channel (K2P2.1), was similarly
expressed using RNA encoding the KCNK2 gene. Hetero-
trimeric GABAA receptors were expressed by a 1 ng oocyte
intranuclear co-injection of three different plasmids
containing cytomegalovirus promoters and coding DNA
for one of thee subunits—human α1 (GABRA1), rat β2
(GABRB2), or rat γ2s (GABRG2 short)—in a 1:1:10 ratio
to ensure incorporation of the γ-subunit; this was
confirmed by demonstrating receptor potentiation to
10 μM chlordiazepoxide during co-application with GABA.
Glycine receptors were expressed by intracytoplasmic
injection of 5 ng RNA per oocyte containing the gene
for the human glycine α1 subunit (GLRA1). Nuclease-
free water-injected oocytes served as negative controls
for all experiments.
Electrophysiology studies
Oocytes were incubated at 18 °C for 1–4 days in fresh
and filtered modified Barth’s solution composed of 88 mM
NaCl, 1 mM KCl, 2.4 mM NaHCO3, 20 mM HEPES,
0.82 mM MgSO4, 0.33 mM Ca(NO3)2, 0.41 mM CaCl2,
5 mM sodium pyruvate, gentamycin, penicillin, strepto-
mycin, and corrected to pH = 7.4. All salts and antibiotics
were A.C.S. grade (Fisher Scientific, Pittsburgh, PA).
Oocytes were studied in a 250 μL linear-flow chamber
perfused with frog Ringer’s (FR) solution composed of
115 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl2, and 10 mM
HEPES prepared in 18.2 MΩ H2O and filtered and
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adjusted to pH = 7.4. All solutions were delivered to the
perfusion chamber via a syringe pump with gastight glass
syringes and foil-wrapped Teflon tubing.at a rate of
1.5 ml/min. Oocytes were impaled by two 3 M KCl-filled
0.2–1 MΩ borosilicate glass electrodes (KG-33, King
Precision Glass, Claremont, CA) connected to separate
headstages (Axon Instruments HS2A, Molecular Devices,
San Jose, CA) through which voltage was measured and
current was passed by use of a computer-controlled
amplifier (Axon Instruments GeneClamp 500B, Molecular
Devices, San Jose, CA) [6].
For oocytes expressing Nav channels, the cell transmem-
brane potential was clamped at -80 mV with a 200 ms step
increase to 0 mV applied approximately every minute.
The Nav channel response was calculated as the difference
between the current required to maintain the holding
potential and the largest negative current deflection
produced by the voltage step. For oocytes expressing
K2P channels, the transmembrane potential was clamped
at −60 mV, and voltage was stepped to + 60 mV each
minute. The K2P channel response was calculated as the
difference between holding potential current and voltage
step plateau current. For both channel types, baseline
responses were measured during oocyte perfusion with FR
for a minimum of three times to demonstrate response
variability <10%. The perfusate was then switched to the
hydrocarbon test drug dissolved at a saturated aqueous
phase concentration in FR for 2 min after which the
current response to the step voltage was measured. The
hydrocarbon drug was then washed out for 5–10 min, and
the current response was again measured to demonstrate
that it was within 10% of the initial baseline response.
For two-electrode voltage clamp studies in oocytes
expressing GABAA receptors or glycine receptors, the
transmembrane potential was clamped at −80 mV while
being perfused with FR. Approximately every 5 min, the
perfusate was switched for 30 s to FR + EC10 agonist—
20 μM 4-aminobutanoic acid for GABAA receptors or
40 μM aminoethanoic acid for glycine receptors—and
then the perfusate was switched back to FR for agonist
washout. The current response for each ligand-gated ion
channel was calculated as the difference between the peak
current measured in the presence of agonist and the
whole-cell current measured immediately prior to agonist
exposure. Baseline responses were measured in triplicate
to confirm <10% variability of current responses in the
absence of drug exposure. Next, the perfusate was
switched to the hydrocarbon test drug dissolved at a
saturated aqueous phase concentration for 2 min followed
by a 30s exposure the same concentration of hydrocarbon
dissolved in FR + agonist. The hydrocarbon drug was then
washed out, and oocytes were exposed to FR + agonist 5
and 10 min later to verify return of the current response
to within 10% of pre-drug baseline levels.
Drug solution preparation
Using predicted density values published in SciFinder
(Chemical Abstracts Service, American Chemical Society,
Columbus OH), drug solutions were prepared by anaer-
obic addition of a hydrocarbon volume to gastight glass
syringes containing either FR or FR + agonist to create a
concentration equal to its calculated molar water solubility
(Table 1). After vigorous agitation, an immiscible hydro-
carbon microbubble could be found in the syringe,
confirming that a saturated solution had been achieved.
However, butane is a gas a room temperature and pressure,
and a saturated aqueous phase cannot be achieved because
butane vapor pressure exceeds atmospheric pressure.
Instead, using FR or FR + agonist containing 1 atm O2
partial pressure in gastight glass syringes, butane drug
solutions were prepared by repeated syringe headspace
exchanges to yield solutions with gas partial pressures
that were 90% butane and 10% O2.
Data analysis
Drug responses were calculated as a percent change
from the control (baseline) current responses as follows:
%change ¼ ID−IBIB , where ID and IB are the current responses
measured during perfusions with drug and without drug
(baseline), respectively. Average current responses for
each drug and channel were described by mean ± SEM.
A positive current change indicated drug-induced positive
allosteric modulation of the channel, whereas a negative
current change indicated negative allosteric modulation
(inhibition) of channel function. A drug-receptor cut-off
response was defined as an absolute value change in
current <10% from baseline that was statistically indistin-
guishable from zero using a two-tailed Student t-test. The
log10 of the calculated solubility (log10S) for compounds
immediately below and above the cut-off for each
hydrocarbon functional group were used to determine
the receptor cut-off. For each hydrocarbon, there was a
“grey area” of indeterminate solubility effect between
sequentially increasing hydrocarbon chain lengths. Mean
solubility cut-offs were calculated as the average log10S
for the least soluble compound that modulated receptor
function and the most soluble neighboring compound for
which no effect was observed. From this result, a 95%
confidence interval for log10S was calculated for receptor
solubility cut-offs.
Results
Sample channel recordings are shown in Fig. 1, and
hydrocarbon effects on each anesthetic-sensitive ion channel
are summarized in Table 2. With increasing carbon addi-
tions to the ω-end or ring, all anesthetic-sensitive channels
exhibited a cut-off effect, defined by <10% channel
modulation, the smallest effect size that is reliably resolved
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Table 1 Source, purity and physical properties of study compounds
Compound CAS# MW (amu) Pvap (mmHg) Solubility (M) Carbon (#) Volume (Å
3) Source Purity (%)
Alcohols
1-octanol 111-87-5 130.23 1.14 × 10− 1 9.0 × 10− 3 8 262 Alfa Aesar >99
1-nonanol 143-08-8 144.25 4.07 × 10− 2 2.7 × 10− 3 9 290 Alfa Aesar >99
1-decanol 112-30-1 158.28 1.48 × 10− 2 6.5 × 10− 4 10 317 Aldrich >99
1-undecanol 112-42-5 172.31 5.10 × 10− 3 1.7 × 10− 4 11 344 Acros 98
1-dodecanol 112-53-8 186.33 2.09 × 10− 3 4.1 × 10− 5 12 372 TCI 99
1-tridecanol 112-70-9 200.36 8.07 × 10− 4 1.2 × 10− 5 13 400 Aldrich 97
1-tetradecanol 112-72-1 214.39 1.47 × 10− 4 2.1 × 10− 6 14 427 Fluka >99
1-pentadecanol 629-76-5 228.41 1.27 × 10− 4 4.7 × 10− 7 15 454 Aldrich 99
Aldehydes
nonanal 124-19-6 142.24 5.32 × 10− 1 2.3 × 10−3 9 289 Aldrich 95
decanal 112-31-2 156.27 2.07 × 10−1 9.8 × 10−4 10 316 Aldrich 98
undecanal 112-44-7 170.29 8.32 × 10− 2 4.2 × 10− 4 11 344 Aldrich 97
dodecanal 112-54-9 184.32 3.44 × 10−2 1.8 × 10−4 12 372 TCI 98
tridecanal 10486-19-8 198.34 1.46 × 10−2 8.2 × 10−5 13 399 TCI 98
tetradecanal 124-25-4 212.37 6.39 × 10−3 3.7 × 10− 5 14 427 TCI 98
heptadecanal 629-90-3 254.45 6.22 × 10−4 3.5 × 10−6 17 509 TCI >97
octadecanal 638-66-4 268.48 3.00 × 10−4 1.7 × 10− 6 18 536 TCI >95
docosanal 57402-36-5 324.58 2.02 × 10−5 9.1 × 10−8 20 646 Alfa Aesar 98
Alkanes
butane 106-97-8 58.12 1.92 × 103 1.4 × 10−3 4 156 Matheson 99.99
pentane 109-66-0 72.15 5.27 × 102 4.3 × 10−4 5 184 Aldrich >99
hexane 110-54-3 86.18 1.51 × 102 1.2 × 10−4 6 211 Acros >99
heptane 142-82-5 100.20 4.52 × 101 3.1 × 10−5 7 239 Acros >99
octane 111-65-9 114.23 1.42 × 101 6.9 × 10−6 8 267 Acros >99
nonane 111-84-2 128.26 4.63 × 100 1.4 × 10− 6 9 294 Acros 99
decane 124-18-5 142.28 1.58 × 100 2.6 × 10−7 10 321 Acros >99
undecane 1120-21-4 156.31 5.64 × 10−1 4.2 × 10−8 11 349 Acros 99
tetradecane 629-59-4 198.39 2.85 × 10−2 6.1 × 10−9 14 431 Aldrich >99
eicosane 112-95-8 282.55 1.40 × 10−4 2.9 × 10−9 20 596 Aldrich 99
Alkenes
1-pentene 109-67-1 70.13 6.37 × 102 1.4 × 10−3 5 176 Aldrich 99
1-hexene 592-41-6 84.16 1.88 × 102 4.2 × 10−4 6 203 Aldrich >99
1-octene 111-66-0 112.21 1.79 × 101 2.6 × 10−5 8 258 Aldrich 98
1-nonene 124-11-8 126.24 5.77 × 100 7.4 × 10−6 9 286 Aldrich 96
1-decene 872-05-9 140.27 1.92 × 100 1.5 × 10− 6 10 313 Aldrich >97
1-undecene 821-95-4 154.29 6.61 × 10−1 2.6 × 10−7 11 341 Aldrich 97
1-dodecene 112-41-4 168.32 2.34 × 10− 1 4.1 × 10−8 12 368 Aldrich >99
1-tridecene 2437-56-1 182.35 8.56 10−2 5.8 × 10−9 13 396 Aldrich 96
Alkynes
1-hexyne 693-02-7 82.14 1.35 × 102 2.9 × 10−3 6 184 Aldrich 97
1-heptyne 628-71-7 96.17 4.35 × 101 6.6 × 10−4 7 212 Acros 99
1-octyne 629-05-0 110.2 1.44 × 101 1.9 × 10− 4 8 239 Acros 99
1-nonyne 3452-09-3 124.22 4.87 × 100 3.9 × 10− 5 9 267 Aldrich 99
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given the given baseline variability allowed in these
studies. All current modulation above this value was
statistically different from baseline.
The mean hydrocarbon molar water solubility cut-off
value and 95% confidence interval range for each ion
channel is as follows (Fig. 2): Nav1.2 = 1.4 mM (0.81 mM–
2.4 mM); Nav1.4 = 1.2 mM (0.62 mM–2.3 mM);
TRESK = 0.59 mM (0.26 mM–1.3 mM); TREK-1 =
0.51 mM (0.24 mM–1.1 mM); GABAA = 120 μM (60 μM–
250 μM); Glycine = 0.63 μM (0.24 μM–1.7 μM). Loss of
ion channel modulation generally occurred in this same
order for all organic compounds, with some clustering
of cut-offs for the Nav and K2P at similar molar water
solubility values.
For each ion channel, the calculated molar water solu-
bility was the only physical-chemical property examined
that was associated with similar cut-off values between
different hydrocarbon functional groups. An example of
this is shown in Fig. 3 in which the grey indeterminate
bars that separate known regions of positive and absent
modulation are clustered around a relatively narrow molar
water solubility cut-off range. Other channels, when simi-
larly graphed as a function of hydrocarbon molar water
solubility, show qualitatively similar results but with
clustering around each channel’s own distinct molar
water solubility cut-off value. In contrast, GABAA receptor
cut-off effects are not associated with the number of
molecular carbon atoms or molecular volume of the
hydrocarbon (Fig. 4), and these results mirror those of the
other anesthetic-sensitive ion channels studied here.
Both Nav channels were inhibited by all of the hydro-
carbons tested above their respective cut-off values, whereas
both of the ligand-gated ion channels (GABAA and glycine
receptors) were potentiated by all compounds above their
respective cut-off values (Table 2). However, the K2P
channels were differently affected by compounds with
different organic functional groups. Both were positively
modulated by alkanes, alkenes, alkynes, cycloalkanes,
and ethers, and both were negatively modulated by
aldehydes and primary amines. However, whereas primary
Table 1 Source, purity and physical properties of study compounds (Continued)
Compound CAS# MW (amu) Pvap (mmHg) Solubility (M) Carbon (#) Volume (Å
3) Source Purity (%)
1-decyne 764-93-2 138.25 1.69 × 100 7.9 × 10−6 10 294 Aldrich 98
1-undecyne 2243-98-3 152.28 6.05 × 10−1 1.4 × 10− 6 11 322 TCI 98
1-dodecyne 765-03-7 166.30 2.22 × 10− 1 2.4 × 10−7 12 349 TCI 98
Amines
1-octadecanamine 124-30-1 269.51 4.88 × 10−5 1.3 × 10−3 18 546 TCI 97
1-eicosanamine 10525-37-8 297.56 8.96 × 10−6 2.7 × 10−4 20 601 Rambus 95
1-hexacosanamine 14130-10-0 381.72 8.91 × 10−8 2.3 × 10−5 26 766 ACC 98
1-octacosanamine 14130-12-2 409.77 2.21 × 10− 8 6.3 × 10−6 28 821 ACC 98
1-triacontanamine 66214-00-4 437.83 5.85 × 10−9 1.8 × 10−6 30 876 ACC 98
Cycloalkanes
cyclopentane 287-92-3 70.13 3.14 × 102 3.3 × 10−3 5 147 Aldrich >99
cyclohexane 110-82-7 84.16 9.37 × 101 1.0 × 10−3 6 176 Aldrich >99.7
cycloheptane 291-64-5 98.19 1.99 × 101 2.9 × 10− 4 7 206 Aldrich 96
cyclooctane 292-64-8 112.21 4.56 × 100 7.2 × 10−5 8 236 Aldrich >99
cyclodecane 293-96-9 140.27 4.47 × 10−1 3.2 × 10−6 10 295 Aldrich 95
cycloundecane 294-41-7 154.29 1.85 × 10− 1 5.7 × 10−7 11 324 Aldrich 95
cyclododecane 294-62-2 168.32 4.13 × 10−2 9.2 × 10−8 12 353 TCI >99
Ethers
dibutyl ether 142-96-1 130.23 7.10 × 100 1.6 × 10− 2 8 277 Aldrich 99.3
dipentyl ether 693-65-2 158.28 1.00 × 100 3.0 × 10−3 10 331 Fluka >98.5
dihexyl ether 112-58-3 186.33 1.48 × 10−1 5.8 × 10−4 12 386 Aldrich 97
diheptyl ether 629-64-1 214.39 2.23 × 10−2 1.2 × 10− 4 14 442 TCI 98
dioctyl ether 629-82-3 242.44 4.53 × 10−3 2.4 × 10−5 16 497 TCI 98
didecyl ether 2456-28-2 298.55 8.08 × 10−5 1.2 × 10−6 20 606 TCI 98
diundecyl ether 43146-97-0 326.60 1.24 × 10−5 2.3 × 10−7 22 661 TCI 98
CAS# Chemical Abstracts Service number, MW molecular weight, Pvap vapor pressure at 25 °C, molar solubility in pure water at pH = 7, and molecular volume are
calculated estimates (rather than measured values) referenced by SciFinder Scholar
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Fig. 1 Sample tracings for (a) Nav1.2 channels, (b) TREK-1 channels, and (c) glycine receptors before and after alcohol exposure at saturated
aqueous phase concentrations (Table 1). Whole cell current responses were qualitatively similar between both Nav channels and between both
K2P channels. Electrophysiologic responses of GABAA receptors during similar hydrocarbon exposure studies have been published elsewhere [6, 7]
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Table 2 Percent change ±SEM of whole-cell currents measured during two-electrode voltage clamp studies in response to
administration of saturated concentration of each hydrocarbon (or 90% atm for butane)
Compound Nav1.2 Nav1.4 TRESK TREK-1 GABAA Glycine
Alcohols
1-octanol 74 ± 5 (5)*
1-nonanol −62 ± 7 (5)* −48 ± 4 (6)* 41 ± 4 (5)* −36 ± 2 (6)*
1-decanol −4 ± 1 (5) − 35 ± 6 (6)* 2 ± 1 (6) −28 ± 4 (6)* 322 ± 29 (5)*
1-undecanol −2 ± 1 (5) − 4 ± 1 (5) 0 ± 2 (5) 81 ± 13 (5)*
1-dodecanol 39 ± 6 (7)*
1-tridecanol 2 ± 1 (6)
1-tetradecanol 5 ± 3 (5) 4 ± 2 (5) 38 ± 6 (6)*
1-pentadecanol −7 ± 2 (5)
Aldehydes
nonanal −51 ± 1 (6)* −22 ± 6 (5)* 119 ± 29 (7)*
decanal −24 ± 3 (5)* −31 ± 3 (6)* −4 ± 2 (5) −45 ± 3 (5)*
undecanal −6 ± 1(5) −2 ± 1 (5) −20 ± 2 (6)*
dodecanal − 5 ± 1 (5)
tridecanal 20 ± 3 (7)*
tetradecanal 5 ± 2 (9)
heptadecanal 31 ± 2 (5)*
octadecanal 20 ± 3 (5)*
docosanal 1 ± 2 (7)
Alkanes
butane −20 ± 2 (7)* −22 ± 2 (5)* 25 ± 5 (6)* 61 ± 9 (5)* 523 ± 68 (5)*
pentane −1 ± 1 (5) − 2 ± 1 (5) 7 ± 1 (5) −3 ± 2 (5) 221 ± 10 (7)*
hexane − 1 ± 0 (2) 4 ± 3 (4) 29 ± 5 (6)* 61 ± 5 (5)*
heptane 0 ± 1 (5) −3 ± 1 (5)
octane − 1 ± 4 (2) 206 ± 21 (5)*
nonane 62 ± 18 (5)*
decane 5 ± 2 (2) 20 ± 3 (6)*
undecane 8 ± 2 (5)
tetradecane 5 ± 1 (5)
eicosane 9 ± 4 (2)
Alkenes
1-pentene −28 ± 2 (5)* −45 ± 4 (5)* 351 ± 38 (6)*
1-hexene 1 ± 1 (5) 0 ± 0 (6) 37 ± 7 (5)* 157 ± 13 (5)* 83 ± 8 (6)*
1-octene 2 ± 1 (5) 1 ± 1 (5) 7 ± 3 (5)
1-nonene 7 ± 4 (6)
1-decene
1-undecene 54 ± 7 (5)*
1-dodecene −3 ± 3 (5)*
1-tridecene 1 ± 1 (5)
Alkynes
1-hexyne −44 ± 2 (5)* −34 ± 2 (5)* 44 ± 5 (5)* 313 ± 23 (6)*
1-heptyne −2 ± 4 (5) −4 ± 2 (6) 29 ± 5 (7)* 55 ± 5 (4)* 78 ± 5 (7)*
1-octyne 2 ± 1 (5) 5 ± 2 (5) −1 ± 2 (9) − 3 ± 1 (6)
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alcohols potentiated TRESK currents, they inhibited
TREK-1 currents.
As increasing hydrocarbon chain length decreased
molar water solubility to values close to a channel cut-
off value, there was commonly a decrease in the magnitude
of current potentiation or inhibition (Table 2). Notable
exceptions to this pattern are cyclohexane with GABAA
receptors and undecyne with glycine receptors. Otherwise,
there appeared no obvious relationship between hydrocar-
bon molar water solubility and either the magnitude or
direction of receptor modulation.
Discussion
As shown previously for NMDA receptors, all of the
anesthetic-sensitive ligand-gated, voltage-gated and leak
channels examined in this study exhibited cut-off effects
for each class of organic compounds, and these cut-offs
were associated with the calculated molar water solubility
of the hydrocarbon. The cut-offs occurred in a predictable
order, with Nav channels K2P channels, and GABAA recep-
tors cut-offs all clustered within roughly one order magni-
tude of saturated drug concentrations. In contrast, the
glycine receptor cut-off was associated with drug molar
water solubility values over two orders of magnitude
lower. If previously determined NMDA receptor results
are included [6], cut-off responses proceed in order of
decreasing hydrocarbon solubility as follows: Nav1.2 ≈
Nav1.4 ≳ NMDA ≳ TRESK ≈ TREK-1 > GABAA >> glycine
(Fig. 2).
Hydrocarbon cut-off responses in the present study,
defined by <10% effect, confirm data available in published
literature. Horishita and Harris [13] found that the ability
of primary alcohols to modulate Nav1.2 channels was lost
between 1-octanol and 1-decanol, and is consistent with
Table 2 Percent change ±SEM of whole-cell currents measured during two-electrode voltage clamp studies in response to
administration of saturated concentration of each hydrocarbon (or 90% atm for butane) (Continued)
Compound Nav1.2 Nav1.4 TRESK TREK-1 GABAA Glycine
1-nonyne 6 ± 1 (4)
1-decyne 7 ± 1 (6) 55 ± 14 (5)*
1-undecyne 223 ± 20 (6)*
1-dodecyne 3 ± 2 (5)
Amines
1-octadecanamine −15 ± 1 (6)* −11 ± 1 (6)* −23 ± 2 (6)* −16 ± 1 (5)* 46 ± 5 (8)*
1-eicosanamine 0 ± 0 (6) − 2 ± 2 (5) −1 ± 1 (7) −2 ± 3 (5) 67 ± 7 (6)*
1-hexacosanamine 0 ± 2 (6) −1 ± 3 (6) 1 ± 2 (6)
1-octacosanamine 26 ± 3 (7)*
1-triacontanamine 2 ± 1 (6)
Cycloalkanes
cyclopentane −45 ± 4 (5)* −11 ± 1 (6)* 63 ± 9 (5)* 68 ± 13 (5)* 93 ± 8 (7)*
cyclohexane −1 ± 1 (5) −2 ± 2 (5) 1 ± 1 (6) 63 ± 6 (6)* 321 ± 17 (5)*
cycloheptane 0 ± 1 (6) 0 ± 1 (5) −4 ± 2 (6) 6 ± 3 (5)
cyclooctane
cyclodecane 22 ± 3 (5)*
cycloundecane 3 ± 2 (5)
cyclododecane 0 ± 1 (5)
Ethers
dibutyl ether −33 ± 3 (5)* −44 ± 5 (5)* 50 ± 9 (6)* 234 ± 24 (5)*
dipentyl ether 1 ± 1 (5) 1 ± 0 (5) 20 ± 2 (8)* 65 ± 6 (6)* 111 ± 9 (7)*
dihexyl ether 0 ± 1 (5) 2 ± 1 (6) 3 ± 2 (6) 13 ± 1 (5)* 143 ± 10 (5)*
diheptyl ether −1 ± 2 (2) −1 ± 4 (5) 74 ± 8 (6)*
dioctyl ether 1 ± 3 (5) 95 ± 8 (5)*
didecyl ether 28 ± 4 (6)*
diundecyl ether 2 ± 2 (7)
Positive changes indicate drug potentiation of channel function, and negative changes indicate drug inhibition of channel function. Drug-induced changes ≥10%
in magnitude in either direction that are significantly greater than zero (not a cut-off response) are indicated by an asterisk. The number of oocytes studied for
each channel and drug combination is shown in parentheses
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our finding of a cut-off between 1-nonanol and 1-decanol
for this channel. Likewise, Peoples and Weight [14]
observed GABAA receptor potentiation with primary
alcohol chains up to 1-dodecanol and a cut-off effect at
1-tridecanol and beyond, exactly where this cut-off was
observed in the present study. The confidence interval
for the GABAA receptor molar water solubility cut-off
from this study also encompasses the calculated solubility
cut-off values for substituted benzene and phenolic
compounds [7].
Discrete water solubility-associated cut-off effects may
be a common feature of all inhaled anesthetic-sensitive
Fig. 2 Summary of ion channel response as a function of hydrocarbon molar water solubility. Hydrocarbons that modulate ion channel function
are indicated by a white bar. Hydrocarbons that did not affect whole cell currents for an ion channel are indicated by a black bar. The grey bar
represents the 95% confidence interval around the mean hydrocarbon molar water solubility cut-off value for each ion channel
Fig. 3 GABAA receptor current potentiation (white bars) and absent whole cell current effects for eight different organic classes graphed as a
function of the calculated hydrocarbon molar water solubility. The grey bars represent hydrocarbon solubility ranges within each organic class for
which GABAA receptor modulation was not evaluated. Cut-off values are clustered between 6.0 × 10
− 5 and 2.5 × 10− 4 M
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ion channels. Conventional volatile and gas anesthetics
immobilize individuals at high aqueous phase concentra-
tions [15] suggesting that they engage in low-affinity
binding with target receptors. We postulate that these
conventional anesthetic-receptor interactions mirror experi-
mental hydrocarbon-receptor interactions, and we propose
a molar water solubility hypothesis to describe non-specific
drug binding to low-affinity and amphipathic allosteric sites
on proteins. Before a ligand can alter protein function, it
must first bind at a site capable of inducing a change in
protein function. In order to bind, water molecules must be
removed from the hydration shell surrounding the drug,
and water molecules within the amphipathic protein pocket
must be displaced. The ease with which the water is
displaced from the protein pocket is described by its dis-
sociation constant (Kd). Water that is only weakly bound to
amino acid side chains within the protein pocket would
have a high Kd and require fewer hydrocarbon molecules to
successfully compete for access to this allosteric site. Conse-
quently, this protein would have a lower molar water solu-
bility cut-off. In contrast, water that is tightly bound within
the pocket would have a low Kd, and therefore a high
hydrocarbon concentration would be necessary to compete
for access to this site. Such a protein would exhibit a high
Fig. 4 Graph of GABAA receptor modulation as a function of the number of carbon atoms in a molecule (Panel a) and as a function of
hydrocarbon molecular volume (Panel b). White and black bars indicate carbon numbers (Panel a) and molecular volumes (Panel b) associated
with receptor potentiation and absent receptor modulation, respectively. Grey bars indicate regions for which hydrocarbon response data is not
available. No pattern of consistent cut-off values associated with hydrocarbon chain length or molecular volume is evident
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drug molar water solubility cut-off. It is possible that ion
channels may have more than one amphipathic allosteric
site for low-affinity interactions with inhaled anesthetics or
other hydrocarbons [16–18]; however the methods
employed in the present study would have identified recep-
tor cut-off effects based only on the amphipathic allosteric
site with the highest water Kd in that receptor and which
would therefore exhibit the lowest hydrocarbon molar water
solubility cut-off effect among all modulatory sites. Other
lower water Kd sites could be important for binding and
modulation by more soluble hydrocarbons and inhaled an-
esthetics when present at sufficient aqueous concentrations.
A second explanation for hydrocarbon molar water
solubility cut-offs is possible. Desolvation of water mole-
cules around the ligand is necessary for protein binding to
occur. However, if the difference in free energy between
the solvated protein-drug complex and the separated sol-
vated protein and solvated drug is too great, then drug
binding will be energetically unfavorable and no modula-
tion of protein function will occur [19]. Larger hydropho-
bic drug ligands are surrounded by larger and more rigid
water shells for which desolvation may be associated with
greater enthalpy. The strength of water complexes around
the ligand might increase to the point that drug receptor
binding—and thus drug-receptor modulation can only
occur if there remains sufficient entropy to overcome
increased enthalpy of binding [20].
In either case, a molar water solubility hypothesis is
not predicated on any particular molecular size, shape,
polarity, functional groups, or atomic arrangement of
the drug for low affinity interactions to take place. Indeed,
the diversity of conventional anesthetics and other hydro-
carbons capable of modulating a single anesthetic-sensitive
ion channel, as well as the relatively minor effect differ-
ences produced by dug enantiomers [21], suggest that
ligand structure itself is not crucial for binding. However,
ligand structure does determine the magnitude and type
of modulation for the protein it binds. Whether there is
inhibition versus potentiation of K2P channel currents, for
example, will depend on the functional group of the
hydrocarbon ligand (Table 2). Modulation magnitude also
differed between functional groups; inhibition of Nav1.4
channels was approximately four times greater for alco-
hols, alkenes, and ethers than for amines or cycloalkanes.
The importance of structural elements within receptor
binding pockets has also been demonstrated through
mutation studies that confer resistance to conventional
anesthetic or other hydrocarbon modulation [22–24],
although it is unknown whether some of these changes
may also have altered the water Kd or drug desolvation
enthalpy that, in turn, could have affected the ability of
the drug to bind the allosteric pocket.
The hydrocarbon molar water solubility cut-off value
for each channel is expressed as confidence intervals,
and certain error is inherent in their measurement.
Butane, the smallest n-alkane studied here, is a gas at
room temperature and pressure, and therefore cannot
be studied at a saturated aqueous phase concentration
under normobaric conditions unlike the other liquid
and solid hydrocarbons. All receptors were nonetheless
modulated by 90% atm of butane, but had current
modulation not been observed, a true cut-off could
have been inferred at this submaximal concentration.
Furthermore, carbon additions to the ω-end of the
hydrocarbon chain produce discrete, non-continuous
changes in molar water solubility. For each series of
functional groups, there is a range of solubility values
that lie between the CN modulating hydrocarbon and
the CN + 1 cut-off hydrocarbon where the receptor effect
is unknown. Most important, however, is the reliance
on calculated solubility values for hydrocarbons in pure
water at 25 °C and pH = 7.0 rather than measured solu-
bility values under study conditions with a 250 mOsm
electrolyte solution at 22 °C and pH = 7.4. Both accurate
measurement and accurate prediction of solubility values
are challenging for extremely hydrophobic compounds or
for large or complex molecules with multiple functional
groups. To limit this problem, only simple aliphatic
compounds with the functional group on the first carbon,
or central and symmetrical in the case of the dialkyl
ethers, were studied. Even so, increasing hydrocarbon
chain length is frequently accompanied by greater diver-
gence between calculated and measured water solubility
values [25, 26].
Whole cell current cut-off responses were measured
using hydrocarbons at saturated aqueous concentrations.
This was done to ensure that each cut-off was independent
of any particular endpoint (e.g., amnesia, unconsciousness,
or immobility). Lack of receptor modulation at a saturated
hydrocarbon concentration implies absent modulation at a
lower pharmacologic concentration, including concentra-
tions relevant to anesthetic endpoints. Anesthetic efficacy
is in mammals is unknown for many, but not all, of the
hydrocarbons tested. Primary alcohol anesthetic potency
increases with increasing carbon chain length from
methanol to dodecanol, after which further carbon
additions do not produce anesthesia at all [27]. This
anesthetic cut-off corresponds to the alcohol molar water
solubility cut-off for GABAA receptors (Table 2). However,
a general anesthesia cut-off effect has been reported to
occur with n-alkanes and dialkyl ethers having around
11-to-15 or more carbon atoms [28] and cycloalkanes
having eight or more carbons atoms [29]. These molecules
are far longer and have molar water solubility values far
lower than occur with the GABAA receptor cut-off.
Although observed anesthetic effects might be due to
glycine receptor modulation, high affinity effects on
one or more other anesthetic-sensitive receptors, or even
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systemic toxicity, it seems very possible that anesthetic
effects could be the result of potent alcohol metabolites
produced by oxidation of alkanes, cycloalkanes, and ethers
by cytochrome P450 enzymes [30, 31]. Since the hydroxyl
group confers greater molar water solubility, primary
alcohols have receptor cut-offs at longer chain lengths
than either alkanes or cycloalkanes or dialkyl ethers. These
long-chain alcohol metabolites are also much more potent
general anesthetics than their parent compounds [32], so
even tiny quantities can have narcotic effects. Identifying
simple parallels between in vitro receptor cut-offs and in
vivo anesthetic cut-offs thus may be complicated for cer-
tain classes of organic compounds.
Channel studies were conducted using a reductionist
biological system. However, in vitro electrophysiologic
responses conducted at room temperature for relevant
anesthetic-sensitive ion channels in oocytes seem to correl-
ate with anesthetic potency in animals [33–35]. Likewise,
the hydrocarbons studied in Table 1 administered in vivo
would be expected to similarly modulate ion channels; in
the case of drugs below the solubility cut-off, no in vivo
modulation would be expected at all.
Finally, the molar water solubility hypothesis could offer
practical applications to the development of new and
novel inhaled anesthetic agents. Conventional volatile
anesthetics bind promiscuously to a variety of cell
proteins, but not all of these receptor interactions are
essential to their ability to produce general anesthesia.
For example, NMDA receptors contribute to immobilizing
actions of inhaled anesthetics able to inhibit their function,
but experimental inhaled anesthetics can still be immobi-
lizers without producing NMDA receptor inhibition [36].
Since there is nearly a 10-fold separation in the hydrocarbon
molar water solubility cut-off effects between NMDA versus
GABAA receptors, a volatile anesthetic might be modified to
target calculated aqueous solubility values within this range
to confer selectivity against higher cut-off NMDA receptors
while preserving activity at lower cut-off GABAA receptors.
With sufficient GABAA receptor potentiation and contribu-
tions of lower cut-off receptors, such an agent might retain
immobilizing potency but lose adverse effects associated
with the modulation of higher cut-off receptors. Conse-
quently, molar water solubility could be key to identifying
volatile anesthetics with new molecular mechanisms of
action and improved pharmacodynamic profiles.
Conclusions
Anesthetic-sensitive ion channels and receptors all appear
to exhibit allosteric cut-off effects associated with drug
molar water solubility. These results support the Molar
Water Solubility Hypothesis mechanism for non-specific
protein interactions with drugs of varied sizes and shapes
administered at relatively high aqueous phase concentra-
tions, such as occurs with inhaled anesthetic agents. Low-
affinity binding at allosteric sites may occur following
successful displacement of water by a hydrocarbon molecule
(or portion thereof). However, when a hydrocarbon has a
molar water solubility below the allosteric cut-off for a
channel, as likely determined by the dissociation constant
for water at the allosteric site, that hydrocarbon cannot be
delivered at a concentration sufficient to outcompete the
water for binding site access. In addition to describing how
anesthetics of various sizes and shapes may be able to
modulate functions of different anesthetic-sensitive ion
channels and receptors, the Molar Water Solubility Hypoth-
esis and order of receptor cut-offs offers a unique tool for
the development of new inhaled anesthetic agents. By
changing substituents on molecules to decrease their
molar water solubility, it may be possible to generate
novel inhaled anesthetics that are selective against some
of the ion channels or receptors normally modulated by
conventional volatile anesthetics.
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